APAC Nutraceutical Trends 2024: Market Hotspots & Product Format Shifts Identified
Analysis of top APAC nutraceutical trends in 2024 reveals significant market potential in key countries and a strong drive towards novel product formats and functional ingredients. Manufacturers must align NPD with region-specific consumer preferences and regulatory pathways.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Singapore, Singapore — 20 December 2024
A review of 2024's most-read nutraceutical trend reports from NutraIngredients-Asia highlights significant shifts and growth drivers across the Asia-Pacific region. Specific markets like Indonesia, South Korea, Taiwan, and Hong Kong present distinct opportunities for manufacturers and brand owners. In Indonesia, consumer behaviour leans reactive rather than preventive; experts recommend 'lifestyle format' products. The per capita spend on vitamins and dietary supplements in Indonesia is US$7.60, considerably behind Vietnam (US$10), China (US$21), Malaysia (US$31.80), and Singapore (US$90.90), underscoring a substantial market gap.
South Korea has seen a surge in 'pill-and-shot' dual-format supplements, a trend initiated by Dong-A Pharmaceutical's distribution of Orthomol products. Major domestic players like CJ Wellcare and CKD Healthcare have rapidly adopted this format, signaling a preference for innovative delivery systems. Additionally, the functional proprietary probiotics market in South Korea is outperforming generic strains, driven by demand for specific health claims such as cognitive support and immune enhancement, as reported by AceBiome CEO Myeong Hee Kim.
Taiwan's nutraceutical sector shows strong demand for eye health, beauty-from-within, and advanced probiotics. The market is also experiencing an influx of food companies and influencers, increasing competitive intensity. Hong Kong's market is characterised by the booming nicotinamide mononucleotide (NMN) category, with women aged 40-50 seeking products to combat fatigue and improve vitality. In China, while bone and joint health remains a cornerstone, fish oil omega-3 and liver health supplements are experiencing rapid growth, prompting brands like Blackmores and GNC to tailor products for local preferences. Vietnam's market, despite modernisation, retains a strong preference for herbal ingredients; close to 70% of products contain botanicals, according to the Vietnam Association of Functional Foods (VAFF).
Australia leads global Google searches for 'gut microbiome', 'gut probiotics', and 'dysbiosis' (2007-2022 data), indicating a high level of consumer awareness and potential demand for advanced gut health solutions. India's nutraceutical growth is propelled by beauty-from-within and sports nutrition for younger consumers, while significant opportunities remain in areas like blood sugar management and Foods for Special Medical Purposes for older demographics, as observed by Setu Nutrition CEO Nihaal Mariwala.
What this means for United Kingdom
UK supplement manufacturers targeting APAC markets must conduct granular market analysis; a one-size-fits-all approach is insufficient. Opportunities exist to license or co-develop novel delivery formats, like South Korea's pill-and-shot, for competitive advantage. Compliance teams must navigate varying regulatory frameworks, particularly for herbal ingredients prevalent in Vietnam and functional claims for proprietary probiotics in South Korea. Ingredient procurement should factor in regional preferences, such as NMN for Hong Kong or traditional botanicals for Vietnam. Brand owners can leverage the high gut health awareness in markets like Australia with advanced probiotic formulations, potentially through strategic distribution partnerships or e-commerce platforms like iHerb, ensuring claims are compliant with local advertising standards.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.